Smoking Cessation Interventions in Clinical Practice
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Epidemiology & Public Health".
Deadline for manuscript submissions: closed (20 October 2021) | Viewed by 4468
Special Issue Editor
Special Issue Information
Dear colleagues,
Worldwide, tobacco use causes more than 7 million deaths per year. Suppose the pattern of smoking all over the globe does not change. In that case, more than 8 million people a year will die from diseases related to tobacco use by 2030. Substantial clinical evidence shows that quitting smoking is one of the most important things a person can do for their health. It's vital to enhance the effectiveness of tobacco cessation interventions. Up until recently, almost only abrupt quitting has been prescribed as the quitting method. However, licensed cessation intervention success rates have been less than satisfying, and new ways have been sought to abstinence. This special issue will look for creative smoking cessation studies and some edifying success stories in tackling tobacco addiction. In this Special Issue, papers on all methods and approaches from complete abstinence from nicotine to harm reduction by, e.g., stopping smoking and switching to other nicotine products, will be considered.
We welcome a broad range of studies examining smoking cessation and quitting intervention and strategies for this Special Issue. In particular, we welcome original research articles or systematic reviews that focus on the following:
- Clinical trials on existing or new nicotine replacement therapy and or pharmacological treatments
- Behavioral modifications cessation studies
- Studies on new tobacco/nicotine products, such as e-cigarettes, snus, and heat but not burn tobacco products
- Smoking cessation among minority groups
- Smoking cessation in low and middle-income countries
Dr. Linda Haddad
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Smoking cessation
- Quitting tobacco products
- Nicotine addiction
- Barriers for quitting
- Tobacco dependency
- Alternative tobacco products
- Vaporized nicotine products
- Evaluation studies
